Fluticasone propionate/salmeterol 250/50 μg versus salmeterol 50 μg after chronic obstructive pulmonary disease exacerbation
Crossref DOI link: https://doi.org/10.1186/s12931-014-0105-2
Published Online: 2014-09-24
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ohar, Jill A
Crater, Glenn D
Emmett, Amanda
Ferro, Thomas J
Morris, Andrea N
Raphiou, Ibrahim
Sriram, Peruvemba S
Dransfield, Mark T
License valid from 2014-09-24
Article History
Received: 14 April 2014
Accepted: 12 August 2014
First Online: 24 September 2014